|
|
Article: Pharma's Shopping Continues, With Focus On Antibody Firms.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Managing Editor
Last year was heavy with M&A activity, and as it drew to a close, Jason Kantor, analyst with RBC Capital Markets, predicted more of the same for 2006, expecting keen interest in firms with antibody technology.
He's been dead on.
"Yeah, I stand by that," he recently told BioWorld Today. "I made these predictions late last year, that the M&As we saw [in 2005], which was a big step up, would continue," with special attention paid to antibody firms.
BioWorld's Snapshots Industry Data show an overall increase of nearly 20 percent in merger and acquisitions worldwide in 2005, up to 179, and through May this year, there have ...
Related newspaper, magazine, and journal articles:
|
|
Article: TARGETING A SLICE OF MARKET HELD BY AMGEN TRANSKARYOTIC, HOECHST ...
BIOWORLD Today;
September 30, 1998 ;
700+ words
... ... Oaks, Calif., in April 1997. The case was administratively closed in April 1998 but could be reopened later. (See BioWorld Today, April 17, 1998, p. 1.) Hoechst, of Frankfurt, Germany, is responsible for all development, clinical work ...
|
|